Ftse Mib
34.456,38
-0,43%
DAX
18.680,20
-0,25%
S&P 500
5.319,54
-0,04%
NASDAQ
16.844,79
0,07%
Bitcoin
70.461,72
0,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Theseus Pharmaceuticals Inc (THRX) Theseus Pharmaceuticals Inc (THRX) Notizie

THRX

Theseus Pharmaceuticals (THRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THRX
DataOraFonteTitoloSimboloCompagnia
26/02/202415:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:THRXTheseus Pharmaceuticals Inc
16/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202420:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202420:22Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202416:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202416:35Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
14/02/202414:30PR Newswire (US)Theseus Pharmaceuticals Announces Closing of Tender OfferNASDAQ:THRXTheseus Pharmaceuticals Inc
13/02/202418:36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
07/02/202423:21Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
30/01/202414:00Business WireConcentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus PharmaceuticalsNASDAQ:THRXTheseus Pharmaceuticals Inc
10/01/202415:47Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:THRXTheseus Pharmaceuticals Inc
10/01/202414:51Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:THRXTheseus Pharmaceuticals Inc
22/12/202312:52Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:THRXTheseus Pharmaceuticals Inc
22/12/202312:30PR Newswire (US)Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value RightNASDAQ:THRXTheseus Pharmaceuticals Inc
27/11/202312:30PR Newswire (US)Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLCNASDAQ:THRXTheseus Pharmaceuticals Inc
24/11/202322:23Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
17/11/202322:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THRXTheseus Pharmaceuticals Inc
15/11/202313:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:THRXTheseus Pharmaceuticals Inc
13/11/202322:05PR Newswire (US)Theseus Pharmaceuticals Announces Process to Explore Strategic AlternativesNASDAQ:THRXTheseus Pharmaceuticals Inc
07/11/202322:05PR Newswire (US)Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:THRXTheseus Pharmaceuticals Inc
10/08/202313:00PR Newswire (US)Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial ResultsNASDAQ:THRXTheseus Pharmaceuticals Inc
14/07/202313:51IH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNASDAQ:THRXTheseus Pharmaceuticals Inc
13/07/202322:05PR Newswire (US)Theseus Pharmaceuticals to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GISTNASDAQ:THRXTheseus Pharmaceuticals Inc
13/06/202323:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:THRXTheseus Pharmaceuticals Inc
09/06/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:THRXTheseus Pharmaceuticals Inc
31/05/202313:00PR Newswire (US)Theseus Pharmaceuticals to Participate in the Jefferies Healthcare ConferenceNASDAQ:THRXTheseus Pharmaceuticals Inc
25/05/202323:01PR Newswire (US)Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GISTNASDAQ:THRXTheseus Pharmaceuticals Inc
11/05/202313:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:THRXTheseus Pharmaceuticals Inc
11/05/202313:00PR Newswire (US)Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial ResultsNASDAQ:THRXTheseus Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THRX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network